Risklick’s data-driven analysis guides trial designers through the decision-making processes for projects in the pre-clinical phase. We provide accurate risk estimates that increase the probability of success (POS). Failure to account for these risks could delay or even prevent smooth and rapid entry into the market.
Our MedDev Intelligence increases POS by deploying real-world data to support portfolio management and decision-making processes. MedDev Intelligence generates a report that highlights and analyzes all relevant POS-associated risks in your clinical development plan, including:
- The competitive landscape
- Market opportunities
- Safety profile of your chosen compounds
- POS estimate
- A historical overview of the clinical research landscape